EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction of an immune-related prognostic signature and lncRNA–miRNA–mRNA ceRNA network in acute myeloid leukemia

Ling Qin, Boya Li, Shijie Wang, Yulai Tang, Aamir Fahira, Yanqi Kou, Tong Li, Zhigang Hu, Zunnan Huang iD

Journal of Leukocyte Biology · 28.06.2024 · 116 (1) · 146-165

DOI: 10.1093/jleuko/qiae041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 23.02.2024. Verfasst von Ling Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, No. 24 Jinghua R…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, RNA, Long Noncoding, MicroRNAs, RNA, Messenger. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Discipline Construction, Guangdong Medical University, National Undergraduate Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The progression of acute myeloid leukemia (AML) is influenced by the immune microenvironment in the bone marrow and dysregulated intracellular competing endogenous RNA (ceRNA) networks. Our study utilized data from UCSC Xena, The Cancer Genome Atlas Program, the Gene Expression Omnibus, and the Immunology Database and Analysis Portal. Using Cox regression analysis, we identified an immune-related prognostic signature. Genomic analysis of prognostic messenger RNA (mRNA) was conducted through Gene Set Cancer Analysis (GSCA), and a prognostic ceRNA network was constructed using the Encyclopedia of RNA Interactomes. Correlations between signature mRNAs and immune cell infiltration, checkpoints, and drug sensitivity were assessed using R software, gene expression profiling interactive analysis (GEPIA), and CellMiner, respectively. Adhering to the ceRNA hypothesis, we established a potential long noncoding RNA (lncRNA)/microRNA (miRNA)/mRNA regulatory axis. Our findings pinpointed 9 immune-related prognostic mRNAs (KIR2DL1, CSRP1, APOBEC3G, CKLF, PLXNC1, PNOC, ANGPT1, IL1R2, and IL3RA). GSCA analysis revealed the impact of copy number variations and methylation on AML. The ceRNA network comprised 14 prognostic differentially expressed lncRNAs (DE-lncRNAs), 6 prognostic DE-miRNAs, and 3 prognostic immune-related DE-mRNAs. Correlation analyses linked these mRNAs’ expression to 22 immune cell types and 6 immune checkpoints, with potential sensitivity to 27 antitumor drugs. Finally, we identified a potential LINC00963/hsa-miR-431-5p/CSRP1 axis. This study offers innovative insights for AML diagnosis and treatment through a novel immune-related signature and ceRNA axis. Identified novel biomarkers, including 2 mRNAs (CKLF, PNOC), 1 miRNA (hsa-miR-323a-3p), and 10 lncRNAs (SNHG25, LINC01857, AL390728.6, AC127024.5, Z83843.1, AP002884.1, AC007038.1, AC112512, AC020659.1, AC005921.3) present promising candidates as potential targets for precision medicine, contributing to the ongoing advancements in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteRNA, Long NoncodingMicroRNAsRNA, MessengerGene Regulatory NetworksHumansPrognosisBiomarkers, TumorGene Expression ProfilingGene Expression Regulation, LeukemicTranscriptomeTumor MicroenvironmentRNA, Competitive Endogenous

Stichwörter der Autor:innen

acute myeloid leukemiacompeting endogenous RNA networkimmune-related geneprognostic signature

Substanzen

RNA, Long NoncodingMicroRNAsRNA, MessengerBiomarkers, TumorRNA, Competitive Endogenous

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, No. 24 Jinghua Road, Jianxi District, Luoyang 471003, China.
  • Key Laboratory of Big Data Mining and Precision Drug Design of Guangdong Medical University, Key Laboratory of Computer-Aided Drug Design of Dongguan City, Key Laboratory for Research and Development of Natural Drugs of…
  • School of Medical Technology and Engineering, Henan University of Science and Technology, No.263 Kaiyuan Avenue, Luolong District, Luoyang 471000, China.

ORCID-Profile: Zunnan Huang

Förderung

  • Key Discipline Construction
  • Guangdong Medical University
  • National Undergraduate Training Program

Zitieren

APA

Qin, L., Li, B., Wang, S., Tang, Y., Fahira, A., Kou, Y., Li, T., Hu, Z., & Huang, Z. (2024). Construction of an immune-related prognostic signature and lncRNA–miRNA–mRNA ceRNA network in acute myeloid leukemia. Journal of Leukocyte Biology, 116(1), 146-165. https://doi.org/10.1093/jleuko/qiae041

Vancouver

Qin L, Li B, Wang S, Tang Y, Fahira A, Kou Y, et al. Construction of an immune-related prognostic signature and lncRNA–miRNA–mRNA ceRNA network in acute myeloid leukemia. Journal of Leukocyte Biology. 2024;116(1):146-165. doi:10.1093/jleuko/qiae041

BibTeX
@article{Qin2024,
  author = {Qin, Ling and Li, Boya and Wang, Shijie and Tang, Yulai and Fahira, Aamir and Kou, Yanqi and Li, Tong and Hu, Zhigang and Huang, Zunnan},
  title = {Construction of an immune-related prognostic signature and lncRNA–miRNA–mRNA ceRNA network in acute myeloid leukemia},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  volume = {116},
  number = {1},
  pages = {146--165},
  doi = {10.1093/jleuko/qiae041}
}
Kostenlos starten →